Flatiron Health is a healthtech company dedicated to improving cancer treatment and advancing research. We provide technology and services to support patient care and make every person’s story count. We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world. Our vision is to build a world where technology and science close the gap between care and research.As the pioneer in real-world evidence for oncology, we provide technology and services to support patient care and make every person’s story count. We partner with hundreds of cancer centers, 20+ top global developers of oncology therapeutics, and researchers and regulators around the world. Our vision is to build a world where technology and science close the gap between care and research.
Enhancing diversity in clinical trails - the time for action is now.
For decades, many groups of individuals have been underrepresented in clinical trials on the basis of race, ethnicity, age, sex, gender and social determinants of health. This lack of representation significantly hampers our understanding of treatment responses in diverse populations, perpetuating cancer care inequities and resulting in poor outcomes among historically marginalized communities. Although enhancing diversity in clinical trials has long been a focus for sponsors, the FDA's 2022 guidance now mandates sponsors develop diversity action plans, ensuring therapies are tested in representative populations.


